Discriminative stimulus effects of ethyl-β-carboline-3-carboxylate at two training doses in rats

Psychopharmacology

Volumn 145, Issue 3, 1999, Pages 324-332

  Rowlett, J K ^a,b   Wilcox, K M ^a   Woolverton, W L ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Benzodiazepine receptor; Drug discrimination; Ethyl carboline 3 carboxylate; Inverse agonist

Indexed keywords

AMPHETAMINE; BENZODIAZEPINE RECEPTOR; BETA CARBOLINE 3 CARBOXYLIC ACID ETHYL ESTER; DIAZEPAM; FLUMAZENIL; MORPHINE; PENTOBARBITAL; SARMAZENIL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DISCRIMINATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARBOLINES; DIAZEPAM; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUMAZENIL; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A;

EID: 0032803146     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051065     Document Type: Article

References (33)

1. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14: 48-58
2. Ator NA, Cook JM, Griffiths RR (1989) Drug discrimination in pentylenetetrazole-trained baboons: Generalization to buspirone and beta-CCE but not lorazepam or pentobarbital. Drug Dev Res 16:257-267
3. Ator NA, Cook JM, Allen MS, Griffiths RR (1994) Discriminative-stimulus effects of azaspirodecanedione anxiolytics in baboons trained to discriminate β-carboline-3-carboxylic acid ethyl ester or pentylenetetrazole. Behav Pharmacol 5:176-188
4. Braestrup C, Schmiechen R, Neef G, Nielsen M, Petersen EN (1982) Interaction of convulsive ligands with benzodiazepine receptors. Science 216:1241-1243
5. Colpaert FC (1988) Intrinsic activity and the discriminative effects of drugs. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli (Psychopharmacology series 4). Springer, Berlin Heidelberg New York, pp 154-160
6. Cowen PJ, Green AR, Martin IL, Nutt DJ (1981) Ethyl β-carboline carboxylate lowers seizure threshold and antagonizes flurazepam-induced sedation in rats. Nature 290:54-55
7. Gardner CR, Budhram P, Parker FL (1992) Discriminative stimulus properties of RU 33965, a benzodiazepine receptor weak partial inverse agonist. Pharmacol Biochem Behav 43:583-588
8. Kirby LG, Rowan GA, Smith RL, Lucki I (1994) Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate (DMCM). Psychopharmacology 113:351-360
9. Kubota K, Itonaga M (1986) β-carbolines selectively antagonize the cholecystokinin action in isolated guinea-pig gallbladder muscle. Jpn J Pharmacol 42:501-506
10. 2 estimation of benzodiazepine receptor antagonists. Methods Find Exp Clin Pharmacol 8:553-555
11. Leidenheimer NJ, Schechter MD (1988) Discriminative stimulus control by the anxiogenic beta-carboline FG 7142: generalization to a physiological stressor. Pharmacol Biochem Behav 30:351-355
12. Leidenheimer NJ, Schechter MD (1991a) Inverse agonist properties of the FG 7142 discriminative stimulus. Pharmacol Biochem Behav 38:99-104
13. Leidenheimer NJ, Schechter MD (1991b) Inverse agonist properties of the THBC discriminative stimulus: asymmetrical generalization with FG 7142. Pharmacol Biochem Behav 38:519-525
14. Leidenheimer NJ, Schechter MD (1992) Evidence for a noradrenergic involvement in mediating the FG 7142 discriminative stimulus. Pharmacol Biochem Behav 43:77-83
15. Lüddens H (1993) Molecular biology of gamma-aminobutyric acid type A/benzodiazepine receptors. In: Stephens DN (ed) Anxiolytic β-carbolines, from molecular biology to the clinic. Springer, Berlin Heidelberg New York, pp 16-28
16. Malizia AL, Nutt DJ (1995) Psychopharmacology of benzodiazepines - an update. Human Psychopharmacol 10:S1-S14
17. Nielsen EB, Jepsen SV, Nielsen M, Braestrup C (1985) Discriminative stimulus properties of methyl 6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate (DMCM), an inverse agonist at benzodiazepine receptors. Life Sci 36:15-23
18. Petersen EN (1983) DMCM: a potent convulsive benzodiazepine receptor ligand. Eur J Pharmacol 94:117-124
19. Petersen EN, Jensen LH (1984) Proconflict effect of benzodiazepine receptor inverse agonists and other inhibitors of GABA function. Eur J Pharmacol 103:91-97
20. A-benzodiazepine receptors produced in transfected cells. Science 245:1389-1392
21. B analyses from behavioral studies. Psychopharmacology 128:1-16
22. Sannerud CA, Ator NA (1995a) Drug discrimination analysis of midazolam under a three-lever procedure I. Dose-dependent differences in generalization and antagonism. J Pharmacol Exp Ther 272:100-111
23. Sannerud CA, Ator NA (1995b) Drug discrimination analysis of midazolam under a three-lever procedure II. Differential effects of benzodiazepine receptor agonists. J Pharmacol Exp Ther 275:183-193
24. Schmiechen R, Seidelmann D, Huth A (1993) β-Carboline-3-carboxylic acid ethyl ester: a lead for new psychotropic drugs. In: Stephens DN (ed) Anxiolytic β-carbolines, from molecular biology to the clinic. Springer, Berlin Heidelberg New York, pp 29-49
25. Shannon HE, Hagen TJ, Guzman F, Cook JA (1988) β-carbolines as antagonists of the discriminative stimulus effects of diazepam in rats. J Pharmacol Exp Ther 246:275-281
26. A receptor inverse agonists modulate γ-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site. Mol Pharmacol 48:965-969
27. Takada K, Winger G, Cook JM, Larscheid P, Woods JH (1986) Discriminative and aversive properties of β-carboline-carboxylic acid ethyl ester, a benzodiazepine receptor inverse agonist, in rhesus monkeys. Life Sci 38:1049-1056
28. 2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci 25:637-654
29. Takemori AE (1974) Determination of pharmacological constants: use of narcotic antagonists to characterize analgesic receptors. In: Braude MS, Harris LS, May EL, Smith JP, Villarreal JE (eds) Narcotic antagonists, vol 8. Advances in biochemical psychopharmacology. Raven Press, New York, pp 335-344
30. Tsuda M, Suzuki T, Misawa M (1997) Role of the NMDA receptor complex in DMCM-induced seizure in mice. Neuroreport 8:603-606
31. Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ (1996) Functional characterization of human γ-aminobutyric acidA receptors containing the a4 subunit. Mol Pharmacol 50:670-678
32. 2 analysis in assessment of opioid abuse liability. Trends Pharmacol Sci 13:282-285
33. Young AM, Masaki MA, Geula C (1992) Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J Pharmacol Exp Ther 261: 246-257